Orion Portfolio Solutions’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-30
Closed -$1K 1179
2020
Q2
$1K Hold
30
﹤0.01% 2000
2020
Q1
$1K Buy
30
+1
+3% +$28 ﹤0.01% 1731
2019
Q4
$1K Buy
+29
New +$789 ﹤0.01% 1672

Other funds holding IDNA

Orion Portfolio Solutions's IDNA Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2020, closing a stake of 30 shares — an estimated $1K sold.

Orion Portfolio Solutions first reported a position in IDNA in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 48 funds tracked by Wall St. Rank hold IDNA as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 30 iShares Genomics Immunology and Healthcare ETF shares in Q3 2020, an estimated $1K.
  • Orion Portfolio Solutions first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's iShares Genomics Immunology and Healthcare ETF position peaked at $1K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.